Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$638M |
| 2 |
Home Depot
HD
|
+$562M |
| 3 |
Costco
COST
|
+$529M |
| 4 |
AbbVie
ABBV
|
+$493M |
| 5 |
Caterpillar
CAT
|
+$461M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$777M |
| 2 |
CELG
Celgene Corp
CELG
|
+$581M |
| 3 |
Booking.com
BKNG
|
+$579M |
| 4 |
Crown Castle
CCI
|
+$495M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$455M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Consumer Discretionary | 15.64% |
| 3 | Financials | 12.8% |
| 4 | Healthcare | 12.56% |
| 5 | Communication Services | 11.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRHC
451
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $11.6M | 0.01% |
412,387
+13,932
| +3% | +$408K |
|
452
Cintas
CTAS
$84.4B
| $11.5M | 0.01% |
+295,248
| New | +$11.2M |
|
|
CIM
453
Chimera Investment
CIM
$1.05B
| $11.2M | 0.01% |
201,432
+108
| +0.1% | +$6.05K |
|
454
Starbucks
SBUX
$118B
| $11.2M | 0.01% |
194,370
-200,564
| -51% | -$11.4M |
|
455
Commault Systems
CVLT
$6.19B
| $11.1M | 0.01% |
211,949
+18,574
| +10% | +$1.03M |
|
456
CALL
Bristol-Myers Squibb
BMY
$128B
| $10.7M | 0.01% |
+175,000
| New | +$10.9M |
|
457
Savara
SVRA
$1.11B
| $10.6M | 0.01% |
+715,670
| New | +$8.21M |
|
458
Glaukos
GKOS
$8.92B
| $10.6M | 0.01% |
+412,919
| New | +$12.3M |
|
|
NSU
459
DELISTED
Nevsun Resources Ltd.
NSU
| $10.5M | 0.01% |
4,314,675
-312,952
| -7% | -$724K |
|
|
NUVA
460
DELISTED
NuVasive, Inc.
NUVA
| $10.3M | 0.01% |
175,978
-3,801
| -2% | -$216K |
|
461
CNX Resources
CNX
$4.77B
| $9.78M | 0.01% |
668,785
-462,124
| -41% | -$6.38M |
|
462
NCS Multistage Holdings
NCSM
$121M
| $9.77M | 0.01% |
33,141
+8,054
| +32% | +$2.98M |
|
463
Huron Consulting
HURN
$1.89B
| $9.74M | 0.01% |
+240,761
| New | +$9.23M |
|
|
SRUNU
464
DELISTED
Silver Run Acquisition Corporation II Units
SRUNU
| $9.68M | 0.01% |
927,116
-15,209
| -2% | -$160K |
|
|
CWEN.A
465
DELISTED
Clearway Energy Class A
CWEN.A
| $9.55M | 0.01% |
506,606
+271
| +0.1% | +$5.09K |
|
466
Agios Pharmaceuticals
AGIO
$2.2B
| $9.51M | 0.01% |
166,255
+190
| +0.1% | +$12K |
|
467
Azenta
AZTA
$1.27B
| $9.35M | 0.01% |
392,147
+319,747
| +442% | +$9.08M |
|
468
Kinross Gold
KGC
$28.6B
| $9.29M | 0.01% |
+2,149,919
| New | +$8.96M |
|
469
WSFS Financial
WSFS
$4.14B
| $9.18M | 0.01% |
191,776
-1,829
| -0.9% | -$90.2K |
|
|
MRTX
470
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $8.9M | 0.01% |
+487,599
| New | +$7.57M |
|
471
Ocular Therapeutix
OCUL
$1.89B
| $8.88M | 0.01% |
1,994,768
+20,132
| +1% | +$103K |
|
472
ProQR Therapeutics
PRQR
$244M
| $8.5M | 0.01% |
2,635,552
+178,192
| +7% | +$640K |
|
|
EIGR
473
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $8.43M | 0.01% |
+20,143
| New | +$7.2M |
|
|
ICD
474
DELISTED
Independence Contract Drilling, Inc.
ICD
| $8.28M | 0.01% |
104,029
-203
| -0.2% | -$14.8K |
|
|
WFT
475
DELISTED
Weatherford International plc
WFT
| $8.14M | 0.01% |
1,951,463
-72,845
| -4% | -$269K |
|
Similar funds
Jennison Associates's Q4 2017 Portfolio in Review
As of Q4 2017, Jennison Associates held 724 positions worth $101B, up 3.7% from $97.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jennison Associates's Q4 2017 filing shows 76 new, 253 increased, 308 reduced and 75 closed positions. Its largest new stake was Block Inc: 2,492,825 shares worth $86.4M. The largest sale was NVIDIA, an estimated $777M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jennison Associates's largest Q4 2017 buy was Block Inc: 2,492,825 shares worth $86.4M.
- Jennison Associates added most to PayPal in Q4 2017, an estimated $638M increase.
- Jennison Associates's biggest Q4 2017 reduction was NVIDIA, cutting an estimated $777M.
- Jennison Associates fully exited Electronic Arts in Q4 2017, selling an estimated $113M.
- Jennison Associates's ten largest holdings make up 27% of its $101B portfolio in Q4 2017.
- Jennison Associates opened 76 new positions and closed 75 in Q4 2017.
- Jennison Associates's portfolio value rose 3.7% quarter-over-quarter to $101B.
Based on Jennison Associates's 13F filing for Q4 2017, filed 25 Jan 2018.